/PRNewswire/ Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the.
/PRNewswire/ Photocure ASA (PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (688176.SH) has obtained approval to.
Press release - Oslo, Norway, March 11, 2022: Photocure ASA , The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has obtained approval to conduct a real-world evidence. | March 11, 2022
/PRNewswire/ Photocure ASA (PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (688176.SH) has obtained approval to.
OSLO, Norway, March 11, 2022 /PRNewswire/ Photocure ASA (PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (688176.SH) has obtained approval to conduct